SI1178799T1 - Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations - Google Patents

Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations

Info

Publication number
SI1178799T1
SI1178799T1 SI200030204T SI200030204T SI1178799T1 SI 1178799 T1 SI1178799 T1 SI 1178799T1 SI 200030204 T SI200030204 T SI 200030204T SI 200030204 T SI200030204 T SI 200030204T SI 1178799 T1 SI1178799 T1 SI 1178799T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical preparations
gastric fluid
obtaining same
microgranules
insoluble
Prior art date
Application number
SI200030204T
Other languages
English (en)
Slovenian (sl)
Inventor
Bruno Criere
Pascal Suplie
Pascal Oury
Original Assignee
Ethypharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9545866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1178799(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm filed Critical Ethypharm
Publication of SI1178799T1 publication Critical patent/SI1178799T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200030204T 1999-05-21 2000-05-19 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations SI1178799T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9906479A FR2793688B1 (fr) 1999-05-21 1999-05-21 Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
PCT/FR2000/001367 WO2000071121A1 (fr) 1999-05-21 2000-05-19 Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
EP00929640A EP1178799B1 (fr) 1999-05-21 2000-05-19 Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques

Publications (1)

Publication Number Publication Date
SI1178799T1 true SI1178799T1 (en) 2003-12-31

Family

ID=9545866

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030204T SI1178799T1 (en) 1999-05-21 2000-05-19 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations

Country Status (35)

Country Link
US (1) US8409612B1 (uk)
EP (1) EP1178799B1 (uk)
JP (2) JP5344781B2 (uk)
KR (1) KR100603915B1 (uk)
CN (1) CN1243546C (uk)
AR (1) AR024036A1 (uk)
AT (1) ATE247960T1 (uk)
AU (1) AU771759B2 (uk)
BG (1) BG65415B1 (uk)
BR (1) BR0010832A (uk)
CA (1) CA2373972C (uk)
CZ (1) CZ302946B6 (uk)
DE (1) DE60004815T2 (uk)
DK (1) DK1178799T3 (uk)
EA (1) EA003943B1 (uk)
EE (1) EE04902B1 (uk)
ES (1) ES2204598T3 (uk)
FR (1) FR2793688B1 (uk)
GE (1) GEP20053580B (uk)
HK (1) HK1042851B (uk)
HR (1) HRP20010940B1 (uk)
HU (1) HU227590B1 (uk)
IL (2) IL146484A0 (uk)
IS (1) IS2160B (uk)
MX (1) MXPA01011973A (uk)
NO (1) NO331643B1 (uk)
PL (1) PL198355B1 (uk)
PT (1) PT1178799E (uk)
RS (1) RS50241B (uk)
SI (1) SI1178799T1 (uk)
SK (1) SK287605B6 (uk)
TR (1) TR200103325T2 (uk)
UA (1) UA72522C2 (uk)
WO (1) WO2000071121A1 (uk)
ZA (1) ZA200109472B (uk)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
ES2234393B2 (es) * 2003-04-29 2006-09-01 Laboratorios Belmac, S.A. "formulaciones de pelets de compuestos bencimidazolicos antiulcerosos y labiles al acido".
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
EP3865120A1 (en) 2013-07-19 2021-08-18 Boehringer Ingelheim Vetmedica GmbH Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
CN110721164B (zh) 2013-12-04 2024-09-17 勃林格殷格翰动物保健有限公司 匹莫苯的改善的药物组合物
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
GB8809421D0 (en) * 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
JPH0768125B2 (ja) 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
US5654009A (en) * 1991-03-25 1997-08-05 Fujisawa Pharmaceutical Co., Ltd. Delayed action preparation
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
FR2692146B1 (fr) 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
HUT75710A (en) * 1994-03-18 1997-05-28 Schmidt The use of dimeticone for the local antibacterial therapy and/or the prevention of helicobacter pylori (hp) associated syndromes and infectious diseases
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
AU3533395A (en) * 1994-09-30 1996-04-26 Takeda Chemical Industries Ltd. Oral sustained-release preparation
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5708017A (en) 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
DE69631981T2 (de) 1995-09-21 2005-04-14 Pharma Pass Ii Llc, Irvine Lansoprazolhaltige Arzneizusammensetzung und Herstellungsverfahren
JPH1029937A (ja) * 1996-05-15 1998-02-03 Kobayashi Seiyaku Kogyo Kk メフェナム酸水溶液製剤
EP0941074B1 (en) 1996-11-06 2004-07-21 Wockhardt Europe Limited Delayed delivery system for acid-sensitive drugs
GB9710800D0 (en) * 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
ES2137862B1 (es) 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
JP4546643B2 (ja) * 1997-12-08 2010-09-15 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸不安定な活性化合物を含有する新規の坐剤形
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
FR2774288B1 (fr) * 1998-01-30 2001-09-07 Ethypharm Sa Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques

Also Published As

Publication number Publication date
DE60004815D1 (de) 2003-10-02
ZA200109472B (en) 2002-08-07
GEP20053580B (en) 2005-07-25
HU227590B1 (hu) 2011-09-28
IL146484A (en) 2006-04-10
YU82301A (sh) 2004-07-15
BR0010832A (pt) 2002-03-05
EP1178799A1 (fr) 2002-02-13
IS6151A (is) 2001-11-08
AU771759B2 (en) 2004-04-01
WO2000071121A1 (fr) 2000-11-30
PL351658A1 (en) 2003-05-19
NO331643B1 (no) 2012-02-13
EE200100615A (et) 2003-02-17
HRP20010940A2 (en) 2003-02-28
JP2011157390A (ja) 2011-08-18
SK287605B6 (sk) 2011-03-04
ATE247960T1 (de) 2003-09-15
IS2160B (is) 2006-11-15
CZ20014155A3 (cs) 2002-04-17
CN1351494A (zh) 2002-05-29
FR2793688A1 (fr) 2000-11-24
ES2204598T3 (es) 2004-05-01
FR2793688B1 (fr) 2003-06-13
DE60004815T2 (de) 2004-06-17
HK1042851A1 (en) 2002-08-30
US8409612B1 (en) 2013-04-02
TR200103325T2 (tr) 2002-05-21
CN1243546C (zh) 2006-03-01
CZ302946B6 (cs) 2012-01-25
CA2373972A1 (fr) 2000-11-30
HUP0201304A3 (en) 2007-11-28
JP5344781B2 (ja) 2013-11-20
WO2000071121A9 (fr) 2002-05-23
AR024036A1 (es) 2002-09-04
CA2373972C (fr) 2011-07-12
IL146484A0 (en) 2002-07-25
NO20015480D0 (no) 2001-11-08
HK1042851B (zh) 2004-01-30
HRP20010940B1 (en) 2004-10-31
KR20020011990A (ko) 2002-02-09
MXPA01011973A (es) 2002-05-06
EA200101221A1 (ru) 2002-04-25
EP1178799B1 (fr) 2003-08-27
HUP0201304A2 (en) 2002-08-28
RS50241B (sr) 2009-07-15
AU4765300A (en) 2000-12-12
UA72522C2 (en) 2005-03-15
EE04902B1 (et) 2007-10-15
BG65415B1 (bg) 2008-07-31
BG106102A (en) 2002-07-31
NO20015480L (no) 2002-01-10
PL198355B1 (pl) 2008-06-30
PT1178799E (pt) 2004-01-30
KR100603915B1 (ko) 2006-07-24
SK16322001A3 (sk) 2002-05-09
JP2003500358A (ja) 2003-01-07
EA003943B1 (ru) 2003-10-30
DK1178799T3 (da) 2003-12-22

Similar Documents

Publication Publication Date Title
HUP0100347A3 (en) Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparation
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
ZA200109859B (en) 6-Alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations.
AU1632601A (en) System and method for pharmacy administration
IL144519A0 (en) 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
HK1020949A1 (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
IL146484A0 (en) Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
HK1036402A1 (en) Morphine sulphate microgranules, method for makingsame and pharmaceutical preparations.
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
HK1047037A1 (en) Pharmaceutical preparations containing nanosols ofchitosan, and their preparation.
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
MXPA01011611A (es) Derivados de espiroimidazolidina, su prepracion, su uso y preparaciones farmaceuticas que los comprenden.
IL146372A0 (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them
SI1169032T1 (sl) Mikrogranule ketoprofena, postopek izdelave in farmacevtska zmes
AU4302200A (en) Ketoprofen microgranules, preparation method and pharmaceutical compositions
GB0002342D0 (en) Apparatus and method for drug administration